Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)
Clinical trial NCT04567810 · COMPLETED
Trial details
- NCT number
- NCT04567810
- Sponsor
- Stanford University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2020-12-14
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.